日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Glucocorticoids elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation

糖皮质激素通过抑制H4K12乳酸化作用,提高透明细胞肾细胞癌对HIF-2α抑制剂的敏感性。

Zhang, Kenan; He, Lin; Wang, Yizhou; Qin, Sen; Yu, Chunyu; Zheng, Enrun; Zhang, Zedan; Xu, Yawei; Chen, Xiaolin; Liu, Yanhua; Liu, Xiaoya; Guan, Sudun; Xia, Lu; Suo, Feiya; Pei, Fei; Du, Juan; Su, Yiran; Li, Yanze; Wu, Yu; Zhou, Xuehong; Zhou, Jingcheng; Cai, Lin; Tang, Xinjing; Zhang, Zheng; Shang, Yongfeng; Zhang, Qing; Gong, Kan; Sun, Luyang

TCF21 promotes epithelial-to-mesenchymal transition and cytoskeleton reorganization in uterine development and endometriosis

TCF21促进子宫发育和子宫内膜异位症中的上皮间质转化和细胞骨架重组

Zhu, Jingwen; Wu, Peili; Ma, Yilei; Peng, Zijun; Fa, Hangwei; Qin, Leyi; Geng, Mengyang; Lu, Ruihui; Zeng, Cheng; Wu, Ning; Zhang, Deyu; Zhang, Chengying; Peng, Chao; Zhou, Yingfang; Shang, Yongfeng; Liang, Jing; Xue, Qing

Correction: LSD1 is required for euchromatic origin firing and replication timing

更正:LSD1 是常染色质起始点激活和复制时序所必需的

Wang, Yue; Huang, Yunchao; Cheng, Edith; Liu, Xinhua; Zhang, Yu; Yang, Jianguo; Young, Jordan T F; Brown, Grant W; Yang, Xiaohan; Shang, Yongfeng

A CMTM6 Nanobody Overcomes EGFR-TKI Resistance in Non-Small Cell Lung Cancer.

CMTM6纳米抗体克服了非小细胞肺癌的EGFR-TKI耐药性

Xia Lu, Wang Jichuan, Xue Hui, Li Haimeng, Li Qinghua, Qin Sen, Yu Chunyu, Liu Yanhua, Gao Yu, Li Lingyun, Guan Sudun, Zheng Enrun, Suo Feiya, He Lin, Wang Yongsheng, Han Wenling, Shang Yongfeng, Geng Yong, Sun Luyang

Structural insights into the substrate uptake and inhibition of the human creatine transporter (hCRT).

人类肌酸转运蛋白 (hCRT) 的底物吸收和抑制的结构见解。

Yuan Xinyi, Yin Jian, Liu Chang, Chen Xudong, Chen Meiying, Wang Yixue, Yang Zi, Wang Yue, Jiang Li, Zhou Niyun, Wang Xiaojuan, Liu Botong, Ma Zhaoqi, Wang Kaiyan, Li Hongen, Zhang Sensen, Shang Yongfeng, Yang Maojun

BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer

BRD4 指导的超级增强子转录抑制程序组织与乳腺癌化疗疗效相关

Liu, Beibei; Liu, Xinhua; Han, Lulu; Chen, Xing; Wu, Xiaodi; Wu, Jiajing; Yan, Dong; Wang, Yue; Liu, Shumeng; Shan, Lin; Zhang, Yu; Shang, Yongfeng

Corrigendum: Ubiquitin ligase RNF20/40 facilitates spindle assembly and promotes breast carcinogenesis through stabilizing motor protein Eg5

更正:泛素连接酶RNF20/40通过稳定运动蛋白Eg5促进纺锤体组装并促进乳腺癌发生。

Duan, Yang; Huo, Dawei; Gao, Jie; Wu, Heng; Ye, Zheng; Liu, Zhe; Zhang, Kai; Shan, Lin; Zhou, Xing; Wang, Yue; Su, Dongxue; Ding, Xiang; Shi, Lei; Wang, Yan; Shang, Yongfeng; Xuan, Chenghao

Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis

USP7 稳定组蛋白去甲基化酶 PHF8 可促进乳腺癌发生

Wang, Qian; Ma, Shuai; Song, Nan; Li, Xin; Liu, Ling; Yang, Shangda; Ding, Xiang; Shan, Lin; Zhou, Xing; Su, Dongxue; Wang, Yue; Zhang, Qi; Liu, Xinhua; Yu, Na; Zhang, Kai; Shang, Yongfeng; Yao, Zhi; Shi, Lei

SCF(JFK) is a bona fide E3 ligase for ING4 and a potent promoter of the angiogenesis and metastasis of breast cancer

SCF(JFK) 是 ING4 的真正 E3 连接酶,也是乳腺癌血管生成和转移的强效促进因子。

Yan, Ruorong; He, Lin; Li, Zhongwu; Han, Xiao; Liang, Jing; Si, Wenzhe; Chen, Zhe; Li, Lei; Xie, Guojia; Li, Wanjin; Wang, Peiyan; Lei, Liandi; Zhang, Hongquan; Pei, Fei; Cao, Dengfeng; Sun, Luyang; Shang, Yongfeng

SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities

SET8促进上皮-间质转化,并赋予TWIST双重转录活性

Yang, Fen; Sun, Luyang; Li, Qian; Han, Xiao; Lei, Liandi; Zhang, Hua; Shang, Yongfeng